← back to search

Carrie Reed

Centers for Disease Control and Prevention · US
🔎 Find collaborators in Epidemiology · Modeling and Simulation →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Epidemiology · Modeling and Simulation
Research interest
Research interests include Influenza Virus Research Studies, Respiratory viral infections research, COVID-19 epidemiological studies, and Data-Driven Disease Surveillance.
h-index
56
citations
21,429
works
253
NIH funding
primary concept
Medicine
email

Recent publications

A time-series approach for estimating emergency department visits attributable to seasonal influenza: results from 6 US cities, 2005-2006 to 2016-2017 seasons.
2026cited by 1position: contributordoi
Challenges in defining severe influenza with implications for measuring and communicating influenza vaccine effects.
2026cited by 0position: contributordoi
Effects of age and birth cohort on influenza A virus subtype-specific hospitalization rates, United States 2010-2025.
2026cited by 0position: contributordoi
Interim Findings: October 2025 – January 2026 Influenza Season in the United States
2026cited by 0position: contributordoi
The Burden of All-Cause Mortality Following Influenza-Associated Hospitalizations: Influenza Hospitalization Surveillance Network, 2010-2019.
2025cited by 11position: contributordoi
Asymptomatic and Mildly Symptomatic Influenza Virus Infections by Season: Case-Ascertained Household Transmission Studies, United States, 2017-2023.
2025cited by 3position: contributordoi
Estimating community-wide indirect effects of influenza vaccination: triangulation using mathematical models and bias analysis.
2025cited by 3position: contributordoi
A Bayesian spatial-temporal varying coefficients model for estimating excess deaths associated with respiratory infections.
2025cited by 1position: contributordoi
Influenza-Associated Hospitalization Rates by Underlying Conditions, 2016-2017 to 2019-2020: A Retrospective Cohort Study.
2025cited by 1position: contributordoi
Modeling the Potential Impacts of Outpatient Antiviral Treatment in Reducing Influenza-Associated Hospitalizations in the United States.
2025cited by 0position: contributordoi
Timing of Influenza Antiviral Therapy and Risk of Death in Adults Hospitalized With Influenza-Associated Pneumonia, Influenza Hospitalization Surveillance Network (FluSurv-NET), 2012–2019
Clinical Infectious Diseases 2024cited by 22position: middledoi
The Burden of All-Cause Mortality Following Influenza-Associated Hospitalizations: Influenza Hospitalization Surveillance Network, 2010–2019
Clinical Infectious Diseases 2024cited by 15position: middledoi
Influenza virus shedding and symptoms: Dynamics and implications from a multiseason household transmission study.
2024cited by 4position: contributordoi
Responding to the Return of Influenza in the United States by Applying Centers for Disease Control and Prevention Surveillance, Analysis, and Modeling to Inform Understanding of Seasonal Influenza.
2024cited by 4position: contributordoi
Detection of Novel Influenza Viruses Through Community and Healthcare Testing: Implications for Surveillance Efforts in the United States.
2024cited by 2position: contributordoi
Asymptomatic and mildly symptomatic influenza virus infections by season -- Case-ascertained household transmission studies, United States, 2017-2023
2024cited by 0position: contributordoi
Severity of influenza-associated hospitalisations by influenza virus type and subtype in the USA, 2010–19: a repeated cross-sectional study
The Lancet Microbe 2023cited by 50position: middledoi
Household Transmission of Influenza A Viruses in 2021-2022
JAMA 2023cited by 42position: middledoi
Comparison of Influenza and Coronavirus Disease 2019-Associated Hospitalizations Among Children Younger Than 18 Years Old in the United States: FluSurv-NET (October-April 2017-2021) and COVID-NET (October 2020-September 2021).
2023cited by 38position: contributordoi
Developing a sampling methodology for timely reporting of population‐based COVID‐19‐associated hospitalization surveillance in the United States, COVID‐NET 2020–2021
Influenza and Other Respiratory Viruses 2023cited by 18position: middledoi
Influenza Antiviral Use in Patients Hospitalized With Laboratory-Confirmed Influenza in the United States, FluSurv-NET, 2015-2019.
2023cited by 11position: contributordoi
Association of Culturable-Virus Detection and Household Transmission of SARS-CoV-2, California and Tennessee, 2020-2022.
2023cited by 7position: contributordoi
Patient and Epidemiological Factors Associated With Influenza Testing in Hospitalized Adults With Acute Respiratory Illnesses, 2016-2017 to 2019-2020.
2023cited by 5position: contributordoi
Acceptability, Feasibility, and Validity of Detecting Respiratory Pathogens During Acute Respiratory Illness in Participant-Collected Swabs in a Low-Income, Community Sample.
2023cited by 3position: contributordoi
Responding to the Return of Influenza in the United States by Applying Centers for Disease Control and Prevention Surveillance, Analysis, and Modeling to Inform Understanding of Seasonal Influenza (Preprint)
2023cited by 0position: contributordoi
Use of At-Home COVID-19 Tests — United States, August 23, 2021–March 12, 2022
MMWR Morbidity and Mortality Weekly Report 2022cited by 241position: middledoi
Comparison of Influenza and Coronavirus Disease 2019–Associated Hospitalizations Among Children Younger Than 18 Years Old in the United States: FluSurv-NET (October–April 2017–2021) and COVID-NET (October 2020–September 2021)
Clinical Infectious Diseases 2022cited by 49position: middledoi
Estimating COVID-19 Hospitalizations in the United States With Surveillance Data Using a Bayesian Hierarchical Model: Modeling Study
JMIR Public Health and Surveillance 2022cited by 42position: lastdoi
Estimating COVID-19 Hospitalizations in the United States With Surveillance Data Using a Bayesian Hierarchical Model: Modeling Study.
2022cited by 29position: contributordoi
Rates of Severe Influenza-Associated Outcomes Among Older Adults Living With Diabetes—Influenza Hospitalization Surveillance Network (FluSurv-NET), 2012–2017
Open Forum Infectious Diseases 2022cited by 26position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 33 papers (2019–2026)Shikha Garg · Centers for Disease Control and Prevention10 papers (2019–2025)H. Keipp Talbot · Vanderbilt University Medical Center10 papers (2020–2025)Carlos G. Grijalva · Vanderbilt University Medical Center9 papers (2016–2025)A Danielle Iuliano · Centers for Disease Control and Prevention9 papers (2021–2026)William Schaffner · Vanderbilt University Medical Center9 papers (2014–2023)Evan J. Anderson · Emory University8 papers (2016–2022)Matthew Biggerstaff · Dermatology Specialists8 papers (2019–2026)Ruth Lynfield · Minnesota Department of Health7 papers (2014–2022)Fiona P. Havers · Centers for Disease Control and Prevention6 papers (2016–2023)Melissa A. Rolfes · Centers for Disease Control and Prevention6 papers (2020–2024)Ann Thomas · Oregon Health Authority6 papers (2014–2022)Alissa O’Halloran · CDC Foundation5 papers (2020–2025)Alicia M. Fry · National Center for Immunization and Respiratory Diseases5 papers (2012–2024)Alexia Couture · 5 papers (2021–2023)Aron J. Hall · Centers for Disease Control and Prevention4 papers (2021–2023)Laurie M. Billing · Ohio Department of Health4 papers (2020–2022)Nancy M. Bennett · University of Rochester4 papers (2014–2021)Sue Kim · Minnesota Department of Health4 papers (2020–2022)Lyn Finelli · Merck & Co., Inc., Rahway, NJ, USA (United States)4 papers (2012–2016)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Epidemiology · Modeling and Simulation →